Neutrophilic eccrine hidradenitis (Q90164): Difference between revisions
From determinar.ia.br - Determine suas informações
Changed an Item |
Changed an Item |
||||||||||||||
| Property / Collection date | |||||||||||||||
13 August 2026
| |||||||||||||||
| Property / Collection date: 13 August 2026 / rank | |||||||||||||||
Normal rank | |||||||||||||||
Latest revision as of 17:07, 15 August 2026
Neutrophilic eccrine hidradenitis is an uncommon cutaneous eruption condition characterised histologically by necrosis of the eccrine epithelium and eccrine secretory coil with a dense surrounding neutrophilic infiltrate. The typical clinical presentation is of solitary or disseminated purpuric macules, nodules or plaques arising on the limbs, neck, face and ears 8–10 days after the start of chemotherapy for malignancy, especially acute myeloid leukaemia. It is often associated with fever and may on occasion simulate bacterial cellulitis. Although most commonly associated with chemotherapy, it has been reported in association with infections in immunodeficient hosts and as a paraneoplastic phenomenon.
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | ID_789957175 |
||
| English | Neutrophilic eccrine hidradenitis |
Neutrophilic eccrine hidradenitis is an uncommon cutaneous eruption condition characterised histologically by necrosis of the eccrine epithelium and eccrine secretory coil with a dense surrounding neutrophilic infiltrate. The typical clinical presentation is of solitary or disseminated purpuric macules, nodules or plaques arising on the limbs, neck, face and ears 8–10 days after the start of chemotherapy for malignancy, especially acute myeloid leukaemia. It is often associated with fever and may on occasion simulate bacterial cellulitis. Although most commonly associated with chemotherapy, it has been reported in association with infections in immunodeficient hosts and as a paraneoplastic phenomenon. |
Statements
CID11:ID_789957175
0 references
dki-india-ID_789957175
0 references
Concluído
0 references
13 August 2026
0 references
